Risa Kagan

Treatment With Once-Weekly Alendronate 70 mg Compared With Once-Weekly Risedronate 35 mg in Women With Postmenopausal Osteoporosis: A Randomized Double-Blind Study

Clifford J. Rosen, Marc C. Hochberg, Sydney Lou Bonnick et al. · Journal of Bone and Mineral Research · 2005 · 337 citations · Full text

Burden of Illness for Osteoporotic Fractures Compared With Other Serious Diseases Among Postmenopausal Women in the United States

Andrea Singer, Alex Exuzides, Leslie Spangler et al. · Mayo Clinic Proceedings · 2014 · 336 citations

Bone Disease, Skeletal Trauma, Bone Health +8

Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women

Robert S. Lindsay, John C. Gallagher, Risa Kagan et al. · Fertility and Sterility · 2009 · 228 citations

Bone Disease, At-risk Postmenopausal Women, Gynecology +9

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health

Stephanie S. Faubion, Lisa Larkin, Cynthia A. Stuenkel et al. · Menopause The Journal of The North American Menopause Society · 2018 · 226 citations

Breast Oncology, Vaginal Hormone Therapies, Cancer Management +18

A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women

Risa Kagan, R. Stanley Williams, Kaijie Pan et al. · Menopause The Journal of The North American Menopause Society · 2010 · 189 citations